Results 211 to 220 of about 177,182 (340)

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Future of Valvular Heart Disease and Structural Heart Interventions: Why So Much Excitement? [PDF]

J Pers Med
Beneki E, Grapsa J.
europepmc   +1 more source

Genetics of Valvular Heart Disease

, 2014
Stephanie LaHaye, Joy Lincoln, Vidu Garg
openalex   +1 more source

Direct Oral Anticoagulant Use in Valvular Heart Disease [PDF]

, 2018
Sarah L. Anderson, Joel C. Marrs
openalex   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Burden of Valvular Heart Disease Diagnosed on Protocolised Echocardiography for Waitlist Placement in End-Stage Kidney Patients. [PDF]

Nephrology (Carlton)
Ho QY, Wong N, Liew IT, Tien CS, Lye YN, Chen H, Ong SZH, Tan JQ, Lee CY, Thangaraju S, Keh YS, Yeo KK, Chua TSJ, Kee T.   +13 more
europepmc   +1 more source

Rapid Ventricular Pacing for Landing Zone Precision During Thoracic Endovascular Aortic Arch Repair: A Case Series. [PDF]

, 2017
Bokoch, Michael P, Hiramoto, Jade S, Lobo, Errol P, Shalabi, Ahmed   +3 more
core   +1 more source

Chronic Valvular Disease of the Heart: Its Etiology, the Factors Leading to Failure of Compensation, and the Symptoms Produced.

, 1914
David MacDonald
openalex   +1 more source

Mid-Term Results of Surgical Treatment of Atrial Fibrillation in Valvular Heart Disease Assesed by Speckle Tracking Echocardiography [PDF]

, 2018
Natalia Lorenzo, Irene Méndez, Mikel Taibo Urquía, Gianfranco Martinis, Sara Badía, Guillermo Reyes, Río Aguilar   +6 more
openalex   +1 more source